Search Results - "Sunal, B. S."

Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib by Gökyer, A., Küçükarda, A., Köstek, O., Hacıoğlu, M. B., Sunal, B. S., Demircan, N. C., Uzunoğlu, S., Solak, S., İşsever, K., Çiçin, İ., Erdoğan, B.

“…Background Sarcopenia is related to poor prognosis and drug toxicities in solid tumors. The aim of our study is to investigate the predisposition of patients…”
Get full text

Skeletal muscle loss during anti-EGFR combined chemotherapy regimens predicts poor prognosis in patients with RAS wild metastatic colorectal cancer by Köstek, O., Demircan, N. C., Gökyer, A., Küçükarda, A., Sunal, B. S., Hacıoğlu, M. B., Eslame, H., Solak, S., Yılmaz, E., Uzunoğlu, S., Tunçbilek, N., Çiçin, İ., Erdoğan, B.

“…Purpose We aimed to assess whether anti-EGFR combined chemotherapy regimens are related with loss of skeletal muscle mass and to compare cetuximab and…”
Get full text

Changing from Aprotinin to Tranexamic Acid Results in Increased Use of Blood Products and Recombinant Factor VIIa for Aortic Surgery Requiring Hypothermic Arrest by Sniecinski, Roman M., MD, Chen, Edward P., MD, Makadia, Sunal S., BS, Kikura, Mutsuhito, MD, Bolliger, Daniel, MD, Tanaka, Kenichi A., MD, MSc

“…Objective Aprotinin, once used to reduce allogeneic blood product transfusion during cardiac surgery, was withdrawn from the market in late 2007 over concerns…”
Get full text